Indications and uses
Temporarily relieves minor aches and pains due to: headache muscular ache minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
Temporarily relieves minor aches and pains due to: headache muscular ache minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
do not take more than directed the smallest effective dose should be used Adults and children 12 years of age and over: ■ Take 1 tablet every 4 to 6 hours while symptoms persist ■ If pain or fever does not respond to 1 tablet, 2 tablets may be used ■ Do not exceed 6 tablets in 24 hours, unless directed by a doctor Children under 12 years of age: ■ Ask a doctor
Important: Read all product information before using.
DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.
Drug Facts
Ibuprofen USP, 200 mg (NSAID)*
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
Temporarily relieves minor aches and pains due to:
Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
Heart attack and stroke warning: NSAIDs, except aspirin, increases the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Adults and children 12 years of age and over:
■ Take 1 tablet every 4 to 6 hours while symptoms persist ■ If pain or fever does not respond to 1 tablet, 2 tablets may be used ■ Do not exceed 6 tablets in 24 hours, unless directed by a doctor
Children under 12 years of age: ■ Ask a doctor
Other information
(White) Carnauba Wax, Croscarmellose Sodium, Hypromellose, Microcrystalline Cellulose, Polyethylene Glycol, Polysorbate 80, Povidone, Pregelatinized Starch, Silicon Dioxide, Sodium Starch Glycolate, Stearic Acid, and Titanium Dioxide.
(Orange) Croscarmellose Sodium, FD&C Yellow #6 Lake, Microcrystalline Cellulose, Polyethylene Glycol, Povidone, Pregelatinized Starch, Silicon Dioxide, Sodium Starch Glycolate, Stearic Acid, Talc and Titanium Dioxide.
(Brown) Croscarmellose Sodium, Hydroxypropylcellulose, Hypromellose, Microcrystalline Cellulose, Polyethylene Glycol, Povidone, Pregelatinized Starch, Red Iron Oxide, Silicon Dioxide, Sodium Starch Glycolate, Stearic Acid, and Titanium Dioxide.
Call 1-800-231-4670: weekdays 9:00 AM to 5:00 PM EST
**This product is not manufactured or distributed by McNeil, owner of the registered trademark Motrin®IB
Manufactured by:
Contract Pharmacal Corp.
135 Adams Avenue
Hauppauge, NY 11788 USA
www.cpc.com
XXXXX-10-18
Barcode
Peel here for more information
See New Warnings
CONTRACT PHARMACAL CORP NDC 10267-3909-2
**Compares to the active ingredient in Motrin
®IB
GLUTEN FREE
Ibuprofen Tablets, USP 200 mg
Pain Reliever/Fever Reducer
(NSAID)
250 Coated Tablets
DYE-FREE
NOT ACTUAL SIZE
See New Warnings
CONTRACT PHARMACAL CORP NDC 10267-3846-2
**Compares to the active ingredient in Motrin
®IB
GLUTEN FREE
Ibuprofen Tablets, USP 200 mg
Pain Reliever/Fever Reducer
(NSAID)
250 Coated Tablets
NOT ACTUAL SIZE
See New Warnings
CONTRACT PHARMACAL CORP NDC 10267-3852-2
**Compares to the active ingredient in Motrin
®IB
GLUTEN FREE
Ibuprofen Tablets, USP 200 mg
Pain Reliever/Fever Reducer
(NSAID)
250 Coated Tablets
NOT ACTUAL SIZE
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10267-3846-2 | ibuprofen | 250 in 1 BOTTLE | TABLET | 250 | 13 | |
| 10267-3852-2 | ibuprofen | 250 in 1 BOTTLE | TABLET | 250 | 13 | |
| 10267-3909-2 | ibuprofen | 250 in 1 BOTTLE | TABLET | 250 | 13 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10267-3846 | IBUPROFEN TABLET [CONTRACT PHARMACAL CORP.] | 13 | Current NDC, Legacy NDC, 1 package rows | 20181120_237bcb87-64a0-415b-bd53-e9d3b8bf33b6.zip |
| 10267-3852 | IBUPROFEN TABLET [CONTRACT PHARMACAL CORP.] | 13 | Current NDC, Legacy NDC, 1 package rows | 20181120_237bcb87-64a0-415b-bd53-e9d3b8bf33b6.zip |
| 10267-3909 | IBUPROFEN TABLET [CONTRACT PHARMACAL CORP.] | 13 | Current NDC, Legacy NDC, 1 package rows | 20181120_237bcb87-64a0-415b-bd53-e9d3b8bf33b6.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | 5 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | 5 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 5 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 5 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 5 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 5 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | 5 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 5 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 5 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 5 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | 5 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 5 | |
| SODIUM STARCH GLYCOLATE TYPE A CORN | INACTIVE INGREDIENT | AG9B65PV6B | 5 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 5 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 5 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 5 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10267-3852 | 10267-3852-2 |
| 10267-3846 | 10267-3846-2 |
| 10267-3909 | 10267-3909-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET / ORAL | 165 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET / ORAL | 165 mg | ||
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / ORAL | 230 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET / ORAL | 2828 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET / ORAL | 2828 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / ORAL | 230 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET / ORAL | 2828 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / ORAL | 230 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET / ORAL | 165 mg | ||
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / ORAL | 230 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A071265-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | ||
| A071265-002 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A071265-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1986-10-15 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A071265-002 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-09-10 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ibuprofen | IBUPROFEN | Contract Pharmacal Corp. | 237bcb87-64a0-415b-bd53-e9d3b8bf33b6 | 2018-11-07 | Warnings | 10267-3852-2 10267-3909-2 10267-3846-2 10267-3909 10267-3852 10267-3846 10267385202 10267384602 10267390902 77cf0092-7436-14ba-e053-2991aa0ac112 237bcb87-64a0-415b-bd53-e9d3b8bf33b6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.